Roche’s Phase III persevERA Trial of Giredestrant Misses Primary Endpoint in Advanced ER-Positive Breast Cancer
BASELINE
Daiichi Sankyo Advances Enhertu for High-Risk Breast Cancer: New Hope After Neoadjuvant Therapy
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
It's Multiple Sclerosis (MS) Awareness Month! Here's what you need to know about this chronic neurological disorder:
🧡 Nearly 1 million people in the U.S. live with MS, and 2.9 million people worldwide
🧡 MS is an autoimmune disease of the central nervous system, where the immune system attacks the brain and spinal cord
🧡 Symptoms vary, but can include vision problems, fatigue, trouble walking, numbness, and muscle weakness
🧡 It's typically diagnosed between ages 20-40
🧡 Women are diagnosed 2-3x more than men
🧡 There are four types of MS with different progression patterns: relapsing-remitting MS (RRMS), primary progressive MS (PPMS), secondary progressive MS (SPMS), and progressive-relapsing MS (PRMS)
🧡 RRMS is the most common, affecting about 85% of people at initial diagnosis
Share to raise awareness and support the MS community! Share your story with us here: bit.ly/4dV7gru #msawarenessmonth #mswarriors #multiplesclerosis #MultipleSclerosisAwarenessMonth
For many people living with rare diseases and chronic illnesses, the hardest work isn’t always visible.
It’s the planning, tracking, researching, advocating, and remembering that happens behind the scenes every single day.
Managing a complex condition often means becoming your own organizer, researcher, and advocate all at once.
If you carry that mental load, we see the effort it takes. And you’re not alone in it.
#RareDisease #ChronicIllness #YouAreNotAlone #PatientWorthy
Tardive Dyskinesia is a serious neurological movement disorder that is often overlooked and misunderstood. Many people live with symptoms for years without answers because TD cannot be diagnosed with a blood test or a scan. Diagnosis depends on awareness, careful observation, and providers taking concerns seriously. Without proper screening, TD is frequently missed or dismissed, which can delay care and affect quality of life. Early diagnosis matters because it allows for monitoring, informed decisions, and access to appropriate care. Raising awareness helps people recognize concerns sooner, ask the right questions, and feel less alone. Listening and screening can change outcomes, and that is why understanding diagnosis and testing for TD is so important. Visit our website patientworthy.com for more information.
#tardivedyskinesia #TDawareness #movementdisorder #PatientWorthy #shareyourstory
